Navigation Links
Common variation in gene linked to structural changes in the brain
Date:8/17/2009

An international group of researchers is the first to show that common variations in a gene previously shown to be associated with Retts Syndrome, autism, and mental retardation are associated with differences in brain structure in both healthy individuals and patients with neurological and psychiatric disorders. Their findings will be published in the early online edition of the Proceedings of the National Academy of Sciences the week of August 17.

"We studied not only the gene itself a gene called MECP2, which is known to have a big effect on brain development but also the regions surrounding the gene, sometimes known as junk DNA," said principle investigator Anders M. Dale, PhD, professor of Neurosciences and Radiology at the University of California, San Diego School of Medicine. "Looking at this 'bigger window' of genetic data, we discovered that common variations in the MECP2 region result in changes to brain structure, even in healthy individuals." Anders explained that these effects do not seem to be population or disease-specific.

The link between genetics and brain structure is a hotly debated area of research. According to the research team, past studies investigating the link between gene variations and human brain structure haven't used the types of refined brain measurements provided by the structural MRI scans and software developed at UC San Diego, or the and full genetic coverage included in the PNAS study.

A team led by Ole A. Andreassen at Ullelvl University Hospital and Institute of Psychiatry in Oslo, Norway, provided data on one cohort a sample from the Thematic Organized Psychosis (TOP) research group. This data was compared to a sample from the Alzheimer's Disease Neuroimaging Initiative (ADNI), the largest Alzheimer's disease study ever funded by the National Institutes of Health, in studies conducted at UC San Diego. The researchers looked at 289 healthy and psychotic subjects from the TOP study, and 655 healthy and demented patients, largely with Alzheimer's disease, from the ADNI study.

"The most statistically significant association between the two groups involved a minor allele of a single polymorphism, an inherited genetic variation that is found in more than one percent of the population," said co-author Nicholas J. Schork, PhD, of the Scripps Translational Science Institute. "This variation resulted in structural brain changes, such as reduced surface area in the brain's cortex, the area that plays a key role in memory, attention, perceptual awareness, thought and language." Although expressed in all cells, the MECP2 gene is developmentally regulated and exists in two different genetic transcripts within the brain's neuronal cells. Changes in brain structure caused by this gene are specific to males, since the variation is found on the X chromosome, but the functional, cognitive consequences aren't yet known.

The fact that broader, common variations in the area surrounding the MECP2 gene also resulted in changes to the brain structure suggests that this gene may be a promising candidate gene for further study, according to Dale. "Since each individual genetic mutation causes only small changes, the so-called 'junk DNA' may be where the action is," he said. These regions may not change the gene or the protein it encodes, but change the regulation of the gene, he added.


'/>"/>

Contact: Debra Kain
ddkain@ucsd.edu
619-543-6163
University of California - San Diego
Source:Eurekalert

Related medicine news :

1. UK junior doctors gaining less experience of common procedures
2. New insights into common knee injuries
3. High and mighty: first common height gene identified by researchers behind obesity gene finding
4. Figure Skater Peggy Fleming, HealthSaver Says: Take Pains For Back Strains, 2nd Most Common Doctor Complaint
5. Exelixis Commences Public Offering of Common Stock
6. Common misdiagnosis: most women believe they have a yeast infection when they dont
7. Business Executives Discuss National Health Care Reform at Conference Sponsored by The Century Foundation, with Support from The Commonwealth Fund, and AARP
8. New Expert Report Dispels Common Myths About Aspartame
9. Common Foot Myths Trip Us Up
10. AHPC Holdings, Inc. Announces Intent to Deregister Common Stock With Securities and Exchange
11. Allergy-Induced Asthma More Common in Affluent Countries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... (PRWEB) , ... July 21, 2017 , ... ... weeks Nature’s Tears® EyeMist®, the signature product of her research center at Bio-Logic ... the world’s largest population and the greatest number of sufferers of blindness. “We ...
(Date:7/21/2017)... TORONTO, ONTARIO, CANADA (PRWEB) , ... July 21, ... ... may give insight into why concussion rates are on the rise, say researchers ... Annual Meeting today in Toronto, Ontario, Canada. , “The combination of evaluating the ...
(Date:7/20/2017)... ... July 20, 2017 , ... ... and application performance monitoring (APM) solutions, has expanded its footprint inside the ... According to Peter Ohrenberger, sales director at Nastel, “We’ve replaced an existing ...
(Date:7/20/2017)... ATLANTA, Ga. (PRWEB) , ... July 20, 2017 , ... ... and equal access to medicine for everyone affected by diabetes, is teaming up with ... the five-day global event kicks off on July 24th. , “Team Type 1’s ...
(Date:7/20/2017)... ... July 20, 2017 , ... ... Webinar**, Aug. 9, 2017 — 1:30 p.m. – 3:00 p.m. ET, http://www.fdanews.com/mdqualitydata ... and boosting quality. , It’s known as the “CY2016 Annual FDA Medical Device ...
Breaking Medicine News(10 mins):
(Date:7/20/2017)... 20, 2017  Prime Therapeutics LLC (Prime) released this statement ... following today,s Institute for Clinical and Economic Review,s (ICER) ... effectiveness and value of abuse-deterrent formulations (ADF) of opioids. Prime ... at the meeting. ... benefit to the use of abuse-deterrent formulations (ADF) in opioids ...
(Date:7/15/2017)... 15, 2017 Enterin Inc., a Philadelphia ... disease (PD), today announced the completion of a $12.7 million ... Ventures III, as well as the participation of existing investors. ... to have the support of New Ventures III and our ... validation of the potential of our platform technology to transform ...
(Date:7/13/2017)... 2017  Centurion Medical Products, a leader in medical product innovation ... impaction removal device for hospice patient care. ... Centurion Medical Products ... Patient pain management and emotional comfort are part of ... patient pain while preventing unneeded emergency department admission due to severe ...
Breaking Medicine Technology: